A Review of Topical Diclofenac Use in Musculoskeletal Disease

Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed medications for the treatment of musculoskeletal disorders. Osteoarthritis is the most common form of arthritis in humans and its prevalence rises with age. Oral NSAIDs have potential associated toxicities that must be monitored f...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Bindu, Taylor-Gjevre, Regina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033958/
https://www.ncbi.nlm.nih.gov/pubmed/27713334
http://dx.doi.org/10.3390/ph3061892
_version_ 1782317904345169920
author Nair, Bindu
Taylor-Gjevre, Regina
author_facet Nair, Bindu
Taylor-Gjevre, Regina
author_sort Nair, Bindu
collection PubMed
description Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed medications for the treatment of musculoskeletal disorders. Osteoarthritis is the most common form of arthritis in humans and its prevalence rises with age. Oral NSAIDs have potential associated toxicities that must be monitored for and can limit the use of these drugs in certain populations including people of older age. Topical NSAIDs are now being recognized as an option for the treatment strategy of osteoarthritis. We review the efficacy and safety of one of the most common topical NSAIDS, topical diclofenac, for the treatment of osteoarthritis.
format Online
Article
Text
id pubmed-4033958
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-40339582014-05-27 A Review of Topical Diclofenac Use in Musculoskeletal Disease Nair, Bindu Taylor-Gjevre, Regina Pharmaceuticals (Basel) Review Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed medications for the treatment of musculoskeletal disorders. Osteoarthritis is the most common form of arthritis in humans and its prevalence rises with age. Oral NSAIDs have potential associated toxicities that must be monitored for and can limit the use of these drugs in certain populations including people of older age. Topical NSAIDs are now being recognized as an option for the treatment strategy of osteoarthritis. We review the efficacy and safety of one of the most common topical NSAIDS, topical diclofenac, for the treatment of osteoarthritis. MDPI 2010-06-11 /pmc/articles/PMC4033958/ /pubmed/27713334 http://dx.doi.org/10.3390/ph3061892 Text en © 2010 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an Open Access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Nair, Bindu
Taylor-Gjevre, Regina
A Review of Topical Diclofenac Use in Musculoskeletal Disease
title A Review of Topical Diclofenac Use in Musculoskeletal Disease
title_full A Review of Topical Diclofenac Use in Musculoskeletal Disease
title_fullStr A Review of Topical Diclofenac Use in Musculoskeletal Disease
title_full_unstemmed A Review of Topical Diclofenac Use in Musculoskeletal Disease
title_short A Review of Topical Diclofenac Use in Musculoskeletal Disease
title_sort review of topical diclofenac use in musculoskeletal disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033958/
https://www.ncbi.nlm.nih.gov/pubmed/27713334
http://dx.doi.org/10.3390/ph3061892
work_keys_str_mv AT nairbindu areviewoftopicaldiclofenacuseinmusculoskeletaldisease
AT taylorgjevreregina areviewoftopicaldiclofenacuseinmusculoskeletaldisease
AT nairbindu reviewoftopicaldiclofenacuseinmusculoskeletaldisease
AT taylorgjevreregina reviewoftopicaldiclofenacuseinmusculoskeletaldisease

Ejemplares similares